About the Program
The goal of the Cerebrovascular Disease and Stroke Program is to provide the highest quality, evidenced-based care for patients and families dealing with stroke, transient ischemic attack, and other cerebrovascular conditions, including brain aneurysms and vascular malformations.
Inpatient care is based in the Neuroscience Unit at Dartmouth-Hitchcock, which includes a ten-bed Neuro Special Care Unit with specialty trained nursing staff. Our cutting edge diagnostic capabilities include MRI and MRA, MR perfusion, conventional (digital subtraction) angiography, among other diagnostic tests. We are actively engaged in clinical research and are participating in the NIH-sponsored stroke prevention trials including POINT (Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial, and CREST-2 (Carotid Revascularization Endarterectomy versus Stenting Trial). Recent program highlights include opening of the Clinical Decision Unit to evaluate patients with transient ischemic attack (December 2014), developing simulation lab training for resident physicians, and launching the first tele-stroke service in the region.
Specific goals for our program include: becoming recognized as a comprehensive center for cerebrovascular care and the regional "hub" of a stroke network that shares resources and improves access to high-quality and cost-effective care for patients in our region, participating in the best clinical trials in our field, bringing relevant basic science and translational research to DHMC, and being a resource for the education of residents, medical students, nurses, primary care providers, and other specialists.
The Cerebrovascular Disease and Stroke Program members strive to meet the needs of stroke patients and their caregivers across the entire continuum of care. We aim to decrease the occurrence of stroke and its complications in the population we serve and advance the field of Cerebrovascular disease care.
Program certifications and awards
Joint Commission Certified Primary Stroke Center
The Stroke Program at Dartmouth-Hitchcock Medical Center has attained advanced certification by The Joint Commission. This means that this program:
- Provides the next generation of stroke care
- Has met and seeks to maintain The Joint Commission’s high standards in providing stroke care
The Joint Commission is an independent, not-for-profit organization that accredits and certifies nearly 21,000 health care organization and programs nationwide.
American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Silver Quality Achievement Award
This award honors hospitals that work to improve stroke care by promoting consistent adherence to the latest scientific treatment guidelines. To receive this award, DHMC demonstrated 85 percent or higher compliance with the Get With The Guidelines®-Stroke key measures for 12 consecutive months. These include appropriate use of medications like tPA, antithrombotics, anticoagulation therapy, DVT prophylaxis, cholesterol-reducing drugs and smoking cessation.
American Heart Association/American Stroke Association’s Target: Stroke Honor Roll
This award recognizes high performance on thrombolytic therapy for ischemic stroke patients – specifically, patients receiving thrombolytic therapy within 60 minutes in 50 percent or more of acute ischemic stroke patients treated with the medication tPA.